nodes	percent_of_prediction	percent_of_DWPC	metapath
Methsuximide—Hyperaemia—Carmustine—brain cancer	0.0485	0.0605	CcSEcCtD
Methsuximide—Gastrointestinal symptom NOS—Hydroxyurea—brain cancer	0.0308	0.0384	CcSEcCtD
Methsuximide—Ataxia—Lomustine—brain cancer	0.0252	0.0314	CcSEcCtD
Methsuximide—CACNA1I—telencephalon—brain cancer	0.0245	0.172	CbGeAlD
Methsuximide—Photophobia—Procarbazine—brain cancer	0.022	0.0274	CcSEcCtD
Methsuximide—Pancytopenia—Lomustine—brain cancer	0.022	0.0274	CcSEcCtD
Methsuximide—Aminophenazone—CYP2C9—brain cancer	0.0204	0.364	CrCbGaD
Methsuximide—CACNA1G—telencephalon—brain cancer	0.0168	0.118	CbGeAlD
Methsuximide—Ataxia—Procarbazine—brain cancer	0.016	0.0199	CcSEcCtD
Methsuximide—Eosinophilia—Procarbazine—brain cancer	0.0145	0.0181	CcSEcCtD
Methsuximide—Leukopenia—Lomustine—brain cancer	0.0144	0.018	CcSEcCtD
Methsuximide—Pancytopenia—Procarbazine—brain cancer	0.0139	0.0174	CcSEcCtD
Methsuximide—CACNA1I—cerebellum—brain cancer	0.0136	0.0957	CbGeAlD
Methsuximide—Drowsiness—Procarbazine—brain cancer	0.0131	0.0163	CcSEcCtD
Methsuximide—Antipyrine—CYP2C9—brain cancer	0.0128	0.229	CrCbGaD
Methsuximide—Anorexia—Lomustine—brain cancer	0.0125	0.0156	CcSEcCtD
Methsuximide—Haematuria—Procarbazine—brain cancer	0.0125	0.0156	CcSEcCtD
Methsuximide—Decreased appetite—Lomustine—brain cancer	0.0114	0.0143	CcSEcCtD
Methsuximide—CACNA1I—brain—brain cancer	0.0111	0.0777	CbGeAlD
Methsuximide—Pancytopenia—Hydroxyurea—brain cancer	0.0108	0.0135	CcSEcCtD
Methsuximide—CACNA1G—head—brain cancer	0.0105	0.0735	CbGeAlD
Methsuximide—Drowsiness—Hydroxyurea—brain cancer	0.0101	0.0126	CcSEcCtD
Methsuximide—Tension—Procarbazine—brain cancer	0.01	0.0125	CcSEcCtD
Methsuximide—Ataxia—Carmustine—brain cancer	0.01	0.0125	CcSEcCtD
Methsuximide—Nervousness—Procarbazine—brain cancer	0.00994	0.0124	CcSEcCtD
Methsuximide—Primidone—CYP2C9—brain cancer	0.00994	0.177	CrCbGaD
Methsuximide—Ataxia—Temozolomide—brain cancer	0.00966	0.0121	CcSEcCtD
Methsuximide—CACNA1G—central nervous system—brain cancer	0.00956	0.0671	CbGeAlD
Methsuximide—CACNA1G—cerebellum—brain cancer	0.00934	0.0656	CbGeAlD
Methsuximide—CACNA1H—gonad—brain cancer	0.00918	0.0644	CbGeAlD
Methsuximide—Leukopenia—Procarbazine—brain cancer	0.00916	0.0114	CcSEcCtD
Methsuximide—CACNA1H—pituitary gland—brain cancer	0.00896	0.0629	CbGeAlD
Methsuximide—Pancytopenia—Carmustine—brain cancer	0.00873	0.0109	CcSEcCtD
Methsuximide—Pancytopenia—Temozolomide—brain cancer	0.00843	0.0105	CcSEcCtD
Methsuximide—Confusional state—Procarbazine—brain cancer	0.00842	0.0105	CcSEcCtD
Methsuximide—Vomiting—Lomustine—brain cancer	0.00837	0.0104	CcSEcCtD
Methsuximide—Weight decreased—Temozolomide—brain cancer	0.00803	0.01	CcSEcCtD
Methsuximide—Anorexia—Procarbazine—brain cancer	0.00796	0.00993	CcSEcCtD
Methsuximide—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.00785	0.00979	CcSEcCtD
Methsuximide—Nausea—Lomustine—brain cancer	0.00781	0.00975	CcSEcCtD
Methsuximide—CACNA1G—brain—brain cancer	0.00759	0.0533	CbGeAlD
Methsuximide—Insomnia—Procarbazine—brain cancer	0.00755	0.00943	CcSEcCtD
Methsuximide—Somnolence—Procarbazine—brain cancer	0.00743	0.00926	CcSEcCtD
Methsuximide—Decreased appetite—Procarbazine—brain cancer	0.00726	0.00906	CcSEcCtD
Methsuximide—Constipation—Procarbazine—brain cancer	0.00714	0.00891	CcSEcCtD
Methsuximide—Leukopenia—Hydroxyurea—brain cancer	0.00709	0.00885	CcSEcCtD
Methsuximide—CACNA1H—endocrine gland—brain cancer	0.00694	0.0487	CbGeAlD
Methsuximide—Feeling abnormal—Procarbazine—brain cancer	0.00688	0.00859	CcSEcCtD
Methsuximide—Gastrointestinal pain—Procarbazine—brain cancer	0.00683	0.00852	CcSEcCtD
Methsuximide—Pancytopenia—Etoposide—brain cancer	0.00675	0.00842	CcSEcCtD
Methsuximide—Erythema multiforme—Temozolomide—brain cancer	0.00672	0.00839	CcSEcCtD
Methsuximide—Urticaria—Procarbazine—brain cancer	0.00664	0.00828	CcSEcCtD
Methsuximide—Abdominal pain—Procarbazine—brain cancer	0.0066	0.00824	CcSEcCtD
Methsuximide—Phenytoin—CYP2C9—brain cancer	0.00655	0.117	CrCbGaD
Methsuximide—Stevens-Johnson syndrome—Etoposide—brain cancer	0.00628	0.00784	CcSEcCtD
Methsuximide—Phenobarbital—CYP2C9—brain cancer	0.00628	0.112	CrCbGaD
Methsuximide—Anorexia—Hydroxyurea—brain cancer	0.00616	0.00769	CcSEcCtD
Methsuximide—CACNA1H—cerebellum—brain cancer	0.00611	0.0429	CbGeAlD
Methsuximide—Vision blurred—Carmustine—brain cancer	0.00603	0.00753	CcSEcCtD
Methsuximide—Vision blurred—Temozolomide—brain cancer	0.00583	0.00728	CcSEcCtD
Methsuximide—Somnolence—Hydroxyurea—brain cancer	0.00575	0.00717	CcSEcCtD
Methsuximide—Leukopenia—Carmustine—brain cancer	0.00573	0.00715	CcSEcCtD
Methsuximide—Diarrhoea—Procarbazine—brain cancer	0.00572	0.00713	CcSEcCtD
Methsuximide—Decreased appetite—Hydroxyurea—brain cancer	0.00562	0.00701	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00558	0.00696	CcSEcCtD
Methsuximide—Leukopenia—Temozolomide—brain cancer	0.00554	0.00691	CcSEcCtD
Methsuximide—Constipation—Hydroxyurea—brain cancer	0.00553	0.0069	CcSEcCtD
Methsuximide—Dizziness—Procarbazine—brain cancer	0.00552	0.00689	CcSEcCtD
Methsuximide—Erythema multiforme—Etoposide—brain cancer	0.00538	0.00671	CcSEcCtD
Methsuximide—Feeling abnormal—Hydroxyurea—brain cancer	0.00533	0.00665	CcSEcCtD
Methsuximide—Vomiting—Procarbazine—brain cancer	0.00531	0.00663	CcSEcCtD
Methsuximide—Confusional state—Carmustine—brain cancer	0.00527	0.00657	CcSEcCtD
Methsuximide—Rash—Procarbazine—brain cancer	0.00527	0.00657	CcSEcCtD
Methsuximide—Dermatitis—Procarbazine—brain cancer	0.00526	0.00656	CcSEcCtD
Methsuximide—Headache—Procarbazine—brain cancer	0.00523	0.00653	CcSEcCtD
Methsuximide—Confusional state—Temozolomide—brain cancer	0.00509	0.00635	CcSEcCtD
Methsuximide—Anorexia—Carmustine—brain cancer	0.00498	0.00621	CcSEcCtD
Methsuximide—CACNA1H—brain—brain cancer	0.00496	0.0348	CbGeAlD
Methsuximide—Nausea—Procarbazine—brain cancer	0.00496	0.00619	CcSEcCtD
Methsuximide—Anorexia—Temozolomide—brain cancer	0.00481	0.00601	CcSEcCtD
Methsuximide—Insomnia—Carmustine—brain cancer	0.00473	0.0059	CcSEcCtD
Methsuximide—Somnolence—Carmustine—brain cancer	0.00465	0.0058	CcSEcCtD
Methsuximide—Insomnia—Temozolomide—brain cancer	0.00457	0.0057	CcSEcCtD
Methsuximide—Decreased appetite—Carmustine—brain cancer	0.00454	0.00567	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Carmustine—brain cancer	0.00451	0.00563	CcSEcCtD
Methsuximide—Somnolence—Temozolomide—brain cancer	0.00449	0.0056	CcSEcCtD
Methsuximide—Constipation—Carmustine—brain cancer	0.00447	0.00558	CcSEcCtD
Methsuximide—Leukopenia—Etoposide—brain cancer	0.00443	0.00553	CcSEcCtD
Methsuximide—Diarrhoea—Hydroxyurea—brain cancer	0.00442	0.00552	CcSEcCtD
Methsuximide—Decreased appetite—Temozolomide—brain cancer	0.00439	0.00548	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Temozolomide—brain cancer	0.00436	0.00544	CcSEcCtD
Methsuximide—Constipation—Temozolomide—brain cancer	0.00432	0.00539	CcSEcCtD
Methsuximide—Feeling abnormal—Carmustine—brain cancer	0.00431	0.00537	CcSEcCtD
Methsuximide—Dizziness—Hydroxyurea—brain cancer	0.00427	0.00533	CcSEcCtD
Methsuximide—Gastrointestinal pain—Carmustine—brain cancer	0.00427	0.00533	CcSEcCtD
Methsuximide—Feeling abnormal—Temozolomide—brain cancer	0.00416	0.00519	CcSEcCtD
Methsuximide—Abdominal pain—Carmustine—brain cancer	0.00413	0.00515	CcSEcCtD
Methsuximide—Gastrointestinal pain—Temozolomide—brain cancer	0.00413	0.00515	CcSEcCtD
Methsuximide—Vomiting—Hydroxyurea—brain cancer	0.00411	0.00513	CcSEcCtD
Methsuximide—Rash—Hydroxyurea—brain cancer	0.00408	0.00509	CcSEcCtD
Methsuximide—Confusional state—Etoposide—brain cancer	0.00407	0.00508	CcSEcCtD
Methsuximide—Dermatitis—Hydroxyurea—brain cancer	0.00407	0.00508	CcSEcCtD
Methsuximide—Headache—Hydroxyurea—brain cancer	0.00405	0.00505	CcSEcCtD
Methsuximide—Urticaria—Temozolomide—brain cancer	0.00401	0.00501	CcSEcCtD
Methsuximide—Abdominal pain—Temozolomide—brain cancer	0.00399	0.00498	CcSEcCtD
Methsuximide—Anorexia—Etoposide—brain cancer	0.00385	0.00481	CcSEcCtD
Methsuximide—Nausea—Hydroxyurea—brain cancer	0.00384	0.00479	CcSEcCtD
Methsuximide—Somnolence—Etoposide—brain cancer	0.00359	0.00448	CcSEcCtD
Methsuximide—Diarrhoea—Carmustine—brain cancer	0.00358	0.00446	CcSEcCtD
Methsuximide—Decreased appetite—Etoposide—brain cancer	0.00351	0.00438	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Etoposide—brain cancer	0.00349	0.00435	CcSEcCtD
Methsuximide—Dizziness—Carmustine—brain cancer	0.00346	0.00431	CcSEcCtD
Methsuximide—Constipation—Etoposide—brain cancer	0.00346	0.00431	CcSEcCtD
Methsuximide—Diarrhoea—Temozolomide—brain cancer	0.00346	0.00431	CcSEcCtD
Methsuximide—Dizziness—Temozolomide—brain cancer	0.00334	0.00417	CcSEcCtD
Methsuximide—Feeling abnormal—Etoposide—brain cancer	0.00333	0.00415	CcSEcCtD
Methsuximide—Vomiting—Carmustine—brain cancer	0.00332	0.00415	CcSEcCtD
Methsuximide—Gastrointestinal pain—Etoposide—brain cancer	0.0033	0.00412	CcSEcCtD
Methsuximide—CYP2C19—endocrine gland—brain cancer	0.0033	0.0232	CbGeAlD
Methsuximide—Rash—Carmustine—brain cancer	0.00329	0.00411	CcSEcCtD
Methsuximide—Dermatitis—Carmustine—brain cancer	0.00329	0.00411	CcSEcCtD
Methsuximide—Headache—Carmustine—brain cancer	0.00327	0.00408	CcSEcCtD
Methsuximide—Vomiting—Temozolomide—brain cancer	0.00321	0.00401	CcSEcCtD
Methsuximide—Urticaria—Etoposide—brain cancer	0.00321	0.00401	CcSEcCtD
Methsuximide—Abdominal pain—Etoposide—brain cancer	0.00319	0.00399	CcSEcCtD
Methsuximide—Rash—Temozolomide—brain cancer	0.00318	0.00397	CcSEcCtD
Methsuximide—Dermatitis—Temozolomide—brain cancer	0.00318	0.00397	CcSEcCtD
Methsuximide—Headache—Temozolomide—brain cancer	0.00316	0.00395	CcSEcCtD
Methsuximide—Nausea—Carmustine—brain cancer	0.0031	0.00387	CcSEcCtD
Methsuximide—Nausea—Temozolomide—brain cancer	0.003	0.00374	CcSEcCtD
Methsuximide—Diarrhoea—Etoposide—brain cancer	0.00276	0.00345	CcSEcCtD
Methsuximide—Dizziness—Etoposide—brain cancer	0.00267	0.00333	CcSEcCtD
Methsuximide—Vomiting—Etoposide—brain cancer	0.00257	0.00321	CcSEcCtD
Methsuximide—Rash—Etoposide—brain cancer	0.00255	0.00318	CcSEcCtD
Methsuximide—Dermatitis—Etoposide—brain cancer	0.00255	0.00318	CcSEcCtD
Methsuximide—Headache—Etoposide—brain cancer	0.00253	0.00316	CcSEcCtD
Methsuximide—Nausea—Etoposide—brain cancer	0.0024	0.00299	CcSEcCtD
